LOX and endothelial dysfunction: Although inducers of endothelial dysfunction commonly downregulate LOX, in human endothelial cells LOX is upregulated by advanced glycation end products (AGEs) via RAGE/MAPK signaling and NF-κΒ and AP-1, thereby impairing endothelial homeostasis [35].